NCT06629714View on ClinicalTrials.gov

Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients

Active, not recruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

October 16, 2025

Study Completion Date

November 1, 2025

Conditions
Non Small Cell Lung CancerImmune Checkpoint InhibitorsInflammationCancer, Treatment-RelatedEmotional DistressGastroesophageal Cancer (GC)Biomarkers / BloodProgression-free Survival, PFS
Interventions
OTHER

Exposure: emotional distress status

The assessment of depressive and anxiety symptoms was conducted using Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder Assessment 7 (GAD-7). Patients with a sum score of PHQ-9 and GAD-7 ≥ 10 were categorized as the stressed group.

Trial Locations (1)

Unknown

Second Affiliated Hospital of Anhui Medical University, Hefei

All Listed Sponsors
lead

Anhui Medical University

OTHER